User profiles for Paul F McKay
 | Paul F. McKayImperial College Verified email at imperial.ac.uk Cited by 4036 |
[HTML][HTML] Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
The spread of the SARS-CoV-2 into a global pandemic within a few months of onset motivates
the development of a rapidly scalable vaccine. Here, we present a self-amplifying RNA …
the development of a rapidly scalable vaccine. Here, we present a self-amplifying RNA …
[HTML][HTML] Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice
Several vaccines have demonstrated efficacy against SARS-CoV-2 mediated disease, yet
there is limited data on the immune response induced by heterologous vaccination regimens …
there is limited data on the immune response induced by heterologous vaccination regimens …
[HTML][HTML] Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA
Self-amplifying RNA (saRNA) is a promising biotherapeutic tool that has been used as a
vaccine against both infectious diseases and cancer. saRNA has been shown to induce protein …
vaccine against both infectious diseases and cancer. saRNA has been shown to induce protein …
Cutting edge: identification of the 2B4 molecule as a counter-receptor for CD48
Y Latchman, PF McKay, H Reiser - The Journal of Immunology, 1998 - journals.aai.org
The CD48 molecule belongs to a subfamily of the Ig superfamily that also includes the CD2,
CD58, 2B4, Signaling lymphocyte activation molecule (SLAM), and Ly-9 molecules. …
CD58, 2B4, Signaling lymphocyte activation molecule (SLAM), and Ly-9 molecules. …
Big is beautiful: enhanced saRNA delivery and immunogenicity by a higher molecular weight, bioreducible, cationic polymer
Self-amplifying RNA (saRNA) vaccines are highly advantageous, as they result in enhanced
protein expression compared to mRNA (mRNA), thus minimizing the required dose. …
protein expression compared to mRNA (mRNA), thus minimizing the required dose. …
Increased transmission of SARS-CoV-2 lineage B. 1.1. 7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape
…, L Baillon, R Kugathasan, AL Pinto, PF McKay… - BioRxiv, 2021 - biorxiv.org
Lineage B.1.1.7 (Variant of Concern 202012/01) is a new SARS-CoV-2 variant which was
first sequenced in the UK in September 2020 before becoming the majority strain in the UK …
first sequenced in the UK in September 2020 before becoming the majority strain in the UK …
[HTML][HTML] Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines
Self-amplifying RNA (saRNA) is a next-generation vaccine platform, but like all nucleic acids,
requires a delivery vehicle to promote cellular uptake and protect the saRNA from …
requires a delivery vehicle to promote cellular uptake and protect the saRNA from …
Neutrophils enable local and non‐invasive liposome delivery to inflamed skeletal muscle and ischemic heart
Uncontrolled inflammation is a major pathological factor underlying a range of diseases
including autoimmune conditions, cardiovascular disease, and cancer. Improving localized …
including autoimmune conditions, cardiovascular disease, and cancer. Improving localized …
[PDF][PDF] Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway
…, F Sweeney, MC Glynn, JL Quantrill, PF McKay… - Cell Reports, 2022 - cell.com
SARS-CoV-2 has a broad mammalian species tropism infecting humans, cats, dogs, and
farmed mink. Since the start of the 2019 pandemic, several reverse zoonotic outbreaks of SARS…
farmed mink. Since the start of the 2019 pandemic, several reverse zoonotic outbreaks of SARS…
[HTML][HTML] Advances in HIV-1 vaccine development
An efficacious HIV-1 vaccine is regarded as the best way to halt the ongoing HIV-1 epidemic.
However, despite significant efforts to develop a safe and effective vaccine, the modestly …
However, despite significant efforts to develop a safe and effective vaccine, the modestly …